[STOK] QoQ Quarter Result on 31-Dec-2021 [#Q4]

Stock
[STOK] Stoke Therapeutics, Inc.
Announcement Date
10-Mar-2022
Financial Year
2021
Quarter
31-Dec-2021 [#Q4]
Profit Trend
QoQ- -8.19%
YoY- -67.90%
Quarter Report
STOK's Result
STOK's Financial Summary
View:
Show?
Quarter Result
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Revenue 2,905 3,231 3,000 0 0 0 0 -
PBT -26,111 -24,652 -24,649 -24,448 -22,597 -21,967 -16,793 34.17%
Tax -2,032 -1,432 -250 -78 -44 -34 -254 299.49%
NP -24,079 -23,220 -24,399 -24,448 -22,597 -21,967 -16,793 27.12%
Tax Rate - - - - - - - -
Total Cost 26,984 26,451 27,399 24,448 22,597 21,967 16,793 37.14%
Ratio Analysis
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
NP Margin -828.88 -718.66 -813.30 0.00 0.00 0.00 0.00 -
Per Share
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
EPS -0.61 -0.59 -0.65 -0.66 -0.61 -0.60 -0.46 20.68%
EPS Diluted -0.61 -0.59 -0.65 -0.66 -0.61 -0.60 -0.46 20.68%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.